Comment optimiser la surveillance des lésions gastriques pré-néoplasiques ? (notice n° 664430)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02815cam a2200313 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121193638.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Bazin, Thomas |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Comment optimiser la surveillance des lésions gastriques pré-néoplasiques ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 66 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The majority of gastric cancer is originated from pre-neoplastic lesions that appear in the previous years. These lesions are dysplasia and, more improperly for pathologists, the atrophy and intestinal metaplasia of the gastric mucosa most often induced by an old Helicobacter pylori infection. Atrophy of the gastric body associated with intestinal metaplasia is a particular risk factor for cancer. There is a beneficial effect of eradication of H. pylori on the development of preneoplastic lesions which have not reached the stage of intestinal metaplasia. In this case monitoring every 3 years is recommended particularly in patients with extensive lesions in the gastric body and antrum or severe lesions whatever the location. In the case of low-grade dysplasia discovered on biopsies, annual endoscopic monitoring is recommended. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | La majorité des cancers gastriques est issue de lésions pré-néoplasiques qui apparaissent plusieurs années auparavant. Ces lésions sont la dysplasie et, plus improprement pour les anatomo-pathologistes, l’atrophie et la métaplasie intestinale de la muqueuse gastrique induites le plus souvent par une infection ancienne à Helicobacter pylori. L’atrophie au niveau du corps gastrique associée à la métaplasie intestinale est un facteur de risque particulier de cancer. Il existe un effet bénéfique de l’éradication de H. pylori sur l’évolution des lésions pré-néoplasiques n’ayant pas atteint le stade de la métaplasie intestinale. Dans ce cas, une surveillance tous les trois ans est recommandée particulièrement chez les patients ayant des lésions étendues dans le corps gastrique et l’antre ou sévères quelle que soit la localisation. En cas de dysplasie de bas grade découverte sur des biopsies étagées, une surveillance annuelle est préconisée. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | atrophie glandulaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | lésions précancéreuses |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | métaplasie intestinale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | estomac |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | surveillance |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | precancerous lesions |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | stomach |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | glandular atrophy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | monitoring |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | intestinal metaplasia |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Julié, Catherine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lamarque, Dominique |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 26 | 7 | 2019-07-01 | p. 646-654 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2019-7-page-646?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-hepato-gastro-et-oncologie-digestive-2019-7-page-646?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux